Skip to Content
Groundbreaking new ultrasound technology capable of diagnosing and monitoring liver disease without the need for surgery has been approved for use by the NHS. The ultrasound technique, called Virtual Touch Quantification™ (VTQ) from Siemens Healthcare, assesses the stiffness of the liver based on readings from invisible, high-intensity shear waves which are transmitted through the liver.
Siemens Healthcare is providing a range of tools and advanced technology to help tackle the perception that cardiac MR is complex and unattainable for widespread use. Cardiovascular disease (CVD) causes more than a quarter of all deaths in the UK, or around 160,000 deaths each year1. A range of innovative MR systems, clinical software applications and imaging coils ensure the most difficult cardiac MR examinations can be simplified, providing more clinicians with the ability to image cardiac patients rapidly and efficiently.